Related Experiment Video
Updated: Jun 12, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Case Report: dynamic monocyte reprogramming during ALSS therapy in type B HBV-ACLF revealed by single-cell
Jiale Xie1, Jiahua Liu1, Feiyu Wang2
1Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Shijiazhuang, Hebei, China.
Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) treatment with artificial liver support systems (ALSS) reprogrammed monocytes. A pro-inflammatory monocyte subpopulation (Mono4) decreased, suggesting ALSS impacts systemic inflammation in HBV-ACLF patients.
Area of Science:
- Immunology
- Hepatology
- Genomics
Background:
- Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) involves intense inflammation and immune dysregulation.
- Monocytes are key players in HBV-ACLF progression.
- Artificial liver support system (ALSS) is a common treatment for HBV-ACLF.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011